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Abstract—Microbubble (MB) volumetric pulsations can be
selectively seeded with external ultrasonic fields. The therapeutic
use of this phenomenon encompass mechanical thrombolysis and
targeted drug deliveries through sonoporating endothelial cells.
However, expected outcomes are still plagued by low bubble
concentrations and short circulation time after administration.
MBs preferentially flow along the centerline of large vessels
which deteriorates biological targeting methodology in the case
of vascular disease treatment with MBs.
Simultaneous MB imaging and trapping against high flow
rates has been recently proposed by instantaneously switching
optimized ultrasonic beams. Principles were previously validated
by circulating MBs with purified water through a flow phantom.
But differences between blood and water call for preliminary
investigations with blood mimicking fluid (BMF). This study
demonstrated the capability of trapping bubbles in BMF with
the acoustic trap but with nearly 40% efficiency reduction over
the control in water, being present by the suppressed increase of
image brightness.
I. INTRODUCTION
Sustained or violent MB oscillations have been used to
enhance interactions with diseased sites and induce therapeutic
bio-effects [1]–[3]. For molecular imaging or treatment of can-
cers, MBs can be functionalized to specifically seek molecular
targets by attaching ligands onto the bubble shell [4]. The
efficacy of the biological MB targeting could be pertinent in
these scenarios, where flow rates are relatively low. Things
are strikingly different in large vessels, where large shear
stress as a result of high flows can easily compete with the
biological bounding force, and deflect bubbles away from the
endothelium [5].
Recent advancements of magnetic particle-doped MBs pro-
vide a means to achieve MB targeting through externally
applying magnetic fields, but with restricted depth of around
20 mm [6], [7]. The use of acoustic radiation force (ARF) to
transport MBs to the distal vascular wall has been appreciated
for years, while the translation is still affected by some
confounding factors [8]. One of the problems is that the
single-element transducer makes the real-time feedback non-
intuitive [9]. With a standard linear array, simultaneous MB
accumulation and imaging has been presented recently by
interleaving fast plane wave and acoustic trap beams [10].
But the existence of particles and high viscosities in blood
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Fig. 1. Simulated acoustic trap beam compared with its counterpart measured
in water.
could impede the MB translation and retention. This study
investigated the feasibility of acoustic MB trapping in BMF
by setting exposures within limits for ultrasound diagnostic
imaging, which is set by the Food and Drug Administration
(FDA) and the British Medical Ultrasound Society (BMUS).
II. MATERIALS AND METHODS
A. Acoustic Trapping and Fast Detection of Contrast Agents
The main driving mechanism behind the acoustic trap is
the interaction between acoustic fields and MBs. Drops of
pressures within the propagating medium produce radiation
forces to push bubbles away from the source [11].
Connected to the Ultrasound Array Research Platform II
[12]–[15], a Verasonics L11-4 transducer (Verasonics, Inc.,
WA, USA) was triggered with a train of pulses to realize MB
trapping and fast imaging. For trapping, central 64 elements
were divided into two sub-groups symmetrically. These two
sub-groups were excited with the same-level voltage at the
same time, but excitations for one sub-aperture were reversed
with pi phase shift before relayed to amplifiers. Consequently,
TABLE I
ULTRASOUND PARAMETERS
Parameter Acoustic Trap Single Plane-Wave Imaging
Number of elements 64 128
Excitation signals sinusoids (7 MHz) square pulse (50 ns)
Mechanical index (MI) 0.07 0.15
traversing the field of view, a low pressure region was en-
gendered because of wave destructive interferences in the
middle. Fig. 1 depicts one typical lateral pressure profile
at the depth of 30 mm which is in accordance with the
vessel depth in experiments. Peak negative pressures (PNPs)
were calibrated with a 0.2 mm needle hydrophone (Precision
Acoustics, Dorchester, UK) in water. The significant ARF
from the inlet beam precluded MBs to enter the trap, and the
duty cycle of the this beam was reduced to a half compared
to that of the outlet beam. For imaging, all elements of 128
were used to perform fast plane wave imaging to secure the
trapping efficiency during excitation switch, and preserve high-
resolution ultrasound imaging. Ultrasound parameters adopted
in experiments are given in Table I.
B. Trapping Experiments
Definity-like MBs were prepared according to [16] and so-
lutions were diluted to a concentration of 1.6x106 bubbles/mL.
The blood mimicking fluid was produced by suspending
Orgasol particles, glycerol, dextran and surfactant into a water
base [17]. MB populations were subsequently flown through a
wall-less flow phantom [18] with purified water or BMF at a
constant flow rate of 28 mL/min. The phantom had a 2.5 mm
vessel and assuming a Newtonian fluid, this flow condition
resulted in a wall shear rate of 304 s−1 that was within the
human venous flow range [19].
The timing of pulse trains is elaborated by Fig. 2 for two
sets of experiments. Noted that trapping pulses were only
interleaved between 100 and 900 ms. A total of 2200 frames
were acquired at an imaging rate of 1 kHz. Three regions
of interest (ROIs) were chosen as given by Fig. 3(a). The
overlaid dashed red line simulates the laterally absolute PNP
profile for trapping. Image brightness was used for arbitration
of MB trapping effect and the baseline was found with 100
frames without introducing MBs. Image intensities were pre-
processed by subtracting the mean value of the baseline
and displayed as a function of time with every 100 frames
averaged.
III. EXPERIMENTAL RESULTS
The ARF produced by the steep slopes of the pressure
field was used for localized trapping of MBs within the
low-pressure trap. Increases of image intensity in the middle
ROI was of primary interest and indicative of the trapping
effect. When circulated by water, compared with its initial
value, the largest brightness gain of 28% was found inside the
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Fig. 2. Timing of emitted pulse sequences in experiments.
middle ROI (Fig. 3(b)). In BMF, MB accumulation was also
achieved with an averaged intensity growth of 17%. (Fig. 3(c)).
Intensities from the outlet ROI dropped after activating the
trapping beam until plateaued with both fluids. Whilst much
more obvious climbs were seen by using water after the ARF
was off. Finally, relatively small fluctuations were observable
in the inlet ROI in Fig. 3(b) and Fig. 3(c).
IV. DISCUSSIONS
In comparison to previously reported work [10], where
ultrasonic exposures (especially ISPAT ) are above FDA limits
for diagnostic imaging, this study investigated the possibility
to halt MB populations in BMF against venous flow rates
with moderate acoustic emissions (all in accordance with FDA
limits for ultrasound imaging).
The presence of scattering particles and higher viscosity of
the BMF makes MBs more resistant to the ARF, delaying the
onset of MB accumulation in the middle ROI (Fig. 3). Akin to
the delayed response to trapping beams, prolonged intensity
increases even after deactivating the acoustic trap is resultant
from the ambient resistance exposed by the BMF.
Thanks to the flexibility of the acoustic trap formation,
which is wholly dependent on the beam control, the ease of
manipulating pressure slopes in the middle makes this tool
applicable to a range of flow rates. The price to pay could
be increased acoustic outputs especially to trap high-speed
flowing MBs in blood.
Compared with the magnetic targeting methodology, a pulse
train can be relayed to a single transducer to perform bubble
localized delivery and imaging with the acoustic trap. Even
further, destructive pulses can be added to burst bubbles and
induce therapeutic effects.
Plane waves were employed to produce the acoustic trap in
this study. Low pressures can be produced along the central
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Fig. 3. (a) ROIs. Temporal MB intensity evolutions in water (b) and BMF
(c) with identical acoustic trap beams interleaved.
line starting from the shallow depth to deep regions. This
removes the need to repeatedly focus at different depths [20].
When targeting deep vessels with the plane-wave based acous-
tic trap, shallow tissues are subject to higher-level exposures
because of the lack of transmission focus and depth-dependent
attenuation. Experiments in this study simulate a deep vein
scenario, results show that accumulating bubbles with opti-
mized ultrasonic beams is feasible within exposure limits for
ultrasound diagnostic imaging.
V. CONCLUSIONS
Acoustic MB trapping in BMF with moderate exposure
conditions was achieved but different from the control in
water, with delayed response to the ARF beam and relatively
suppressed increase of image intensity. The flow rate of 28
mL/min is within the upper band of venous flows. Results
indicate that the acoustic trap could benefit thrombolysis in
deep veins, where trapped bubbles would act as cavitation
nuclei and locally amplify bio-mechanical effects.
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